Search Results - "Peltonen, L."

Refine Results
  1. 1

    Is it advantageous to use quality by design (QbD) to develop nanoparticle-based dosage forms for parenteral drug administration? by Camacho Vieira, C., Peltonen, L., Karttunen, A.P., Ribeiro, A.J.

    Published in International journal of pharmaceutics (25-05-2024)
    “…[Display omitted] Parenteral administration is one of the most commonly used drug delivery routes for nanoparticle-based dosage forms, such as lipid-based and…”
    Get full text
    Journal Article
  2. 2

    A new highly penetrant form of obesity due to deletions on chromosome 16p11.2 by Froguel, P, Beckmann, J. S, Walters, R. G, Jacquemont, S, Valsesia, A, de Smith, A. J, Martinet, D, Andersson, J, Falchi, M, Chen, F, Andrieux, J, Lobbens, S, Delobel, B, Stutzmann, F, El-Sayed Moustafa, J. S, Chèvre, J.-C, Lecoeur, C, Vatin, V, Bouquillon, S, Buxton, J. L, Boute, O, Holder-Espinasse, M, Cuisset, J.-M, Lemaitre, M.-P, Ambresin, A.-E, Brioschi, A, Gaillard, M, Giusti, V, Fellmann, F, Ferrarini, A, Hadjikhani, N, Campion, D, Guilmatre, A, Goldenberg, A, Calmels, N, Mandel, J.-L, Le Caignec, C, David, A, Isidor, B, Cordier, M.-P, Dupuis-Girod, S, Labalme, A, Sanlaville, D, Béri-Dexheimer, M, Jonveaux, P, Leheup, B, Õunap, K, Bochukova, E. G, Henning, E, Keogh, J, Ellis, R. J, MacDermot, K. D, van Haelst, M. M, Vincent-Delorme, C, Plessis, G, Touraine, R, Philippe, A, Malan, V, Mathieu-Dramard, M, Chiesa, J, Blaumeiser, B, Kooy, R. F, Caiazzo, R, Pigeyre, M, Balkau, B, Sladek, R, Bergmann, S, Mooser, V, Waterworth, D, Reymond, A, Vollenweider, P, Waeber, G, Kurg, A, Palta, P, Esko, T, Metspalu, A, Nelis, M, Elliott, P, Hartikainen, A.-L, McCarthy, M. I, Peltonen, L, Carlsson, L, Jacobson, P, Sjöström, L, Huang, N, Hurles, M. E, O'Rahilly, S, Farooqi, I. S, Männik, K, Jarvelin, M.-R, Pattou, F, Meyre, D, Walley, A. J, Coin, L. J. M, Blakemore, A. I. F

    Published in Nature (London) (04-02-2010)
    “…Obesity has become a major worldwide challenge to public health, owing to an interaction between the Western 'obesogenic' environment and a strong genetic…”
    Get full text
    Journal Article
  3. 3

    Development of an instrument for the evaluation of advanced life support performance by Peltonen, L.‐M., Peltonen, V., Salanterä, S., Tommila, M.

    Published in Acta anaesthesiologica Scandinavica (01-10-2017)
    “…Background Assessing advanced life support (ALS) competence requires validated instruments. Existing instruments include aspects of technical skills (TS),…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy by Savolainen, M., Kogermann, K., Heinz, A., Aaltonen, J., Peltonen, L., Strachan, C., Yliruusi, J.

    “…Amorphous drugs have a higher kinetic solubility and dissolution rate than their crystalline counterparts. However, this advantage is lost if the amorphous…”
    Get full text
    Journal Article
  8. 8

    Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension by Surwase, S.A., Itkonen, L., Aaltonen, J., Saville, D., Rades, T., Peltonen, L., Strachan, C.J.

    “…[Display omitted] This study reports the potential of different polymers and polymer incorporation methods to inhibit crystallisation and maintain…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Parkinsonism, premature menopause, and mitochondrial DNA polymerase γ mutations: clinical and molecular genetic study by Luoma, Petri, Melberg, Atle, Rinne, Juha O, Kaukonen, Jyrki A, Nupponen, Nina N, Chalmers, Richard M, Oldfors, Anders, Rautakorpi, Ilkka, Peltonen, Leena, Majamaa, Kari, Somer, Hannu, Suomalainen, Anu

    Published in The Lancet (British edition) (04-09-2004)
    “…Mutations in the gene encoding mitochondrial DNA polymerase γ ( POLG), the enzyme that synthesises mitochondrial DNA (mtDNA), have been associated with a…”
    Get full text
    Journal Article
  15. 15

    Replication of 1q42 linkage in Finnish schizophrenia pedigrees by EKELUND, J, HENNAH, W, HIEKKALINNA, T, PARKER, A, MEYER, J, LÖNNQVIST, J, PELTONEN, L

    Published in Molecular psychiatry (01-11-2004)
    “…Chromosome 1q has been implicated in the etiology of schizophrenia in several independent studies. However, the peak linkage findings have been dispersed over…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Association of DISC1 with autism and Asperger syndrome by Kilpinen, H, Ylisaukko-oja, T, Hennah, W, Palo, O M, Varilo, T, Vanhala, R, Nieminen-von Wendt, T, von Wendt, L, Paunio, T, Peltonen, L

    Published in Molecular psychiatry (01-02-2008)
    “…The DISC1 gene at 1q42 has generated considerable interest in various psychiatric diseases, since a balanced translocation interrupting the gene was found to…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Brief report: validity of Finnish registry-based diagnoses of autism with the ADI-R by Lampi, KM, Sourander, A, Gissler, M, Niemelä, S, Rehnström, K, Pulkkinen, E, Peltonen, L, Von Wendt, L

    Published in Acta Paediatrica (01-09-2010)
    “…Aims:  The aim of the study was to explore the validity of registry‐based diagnoses of autism in Finland using the Autism Diagnostic Interview – Revised…”
    Get full text
    Journal Article